We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

Product News   Apr 26, 2019

 
TC BioPharm Initiates Phase I Trial of Allogeneic Gamma Delta T Cell Therapy in Acute Myeloid Leukemia Patients

The ÚHKT and TCB clinical teams pictured in the Prague trial center.

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Microfluidizer Offers Effective Cell Disruption

Product News

Analytik reports on how the School of Biological & Chemical Sciences at Queen Mary University, London (QMUL) has been using a LM20 Microfluidizer for cell disruption of a broad range of cell types including E. coli, Yeasts and Diatom.

READ MORE

Leiden University Medical Centre and Biotech Support Group Enter Joint Research Agreement for Stromal Conditioning Biomarkers in Cancer

Product News

Objectives are to characterize and quantify Stroma Liquid Biopsy™ biomarkers so as to correlate to the Tumor-Stroma Ratio scoring methods developed by Leiden University.

READ MORE

Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension

Product News

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine announces a strategic collaboration with Actelion Pharmaceuticals Ltd.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE